| NAME |
RIVAROXABAN 15MG X 42/20MG X 9 TITRATION PACK,51 |
| VA GENERIC NAME |
RIVAROXABAN |
| DOSAGE FORM |
TAB |
| FDA MED GUIDE |
Rivaroxaban_(Xarelto)_(2023).pdf |
| FORMULARY DESIGNATOR |
PA-F |
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| NATIONAL FORMULARY NAME |
RIVAROXABAN TAB |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
RIVAROXABAN 15MG X 42/20MG X 9 PACK 51 |
| VA PRODUCT IDENTIFIER |
R0338 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
PKG |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4033754 |
| EFFECTIVE DATE/TIME |
-
- 2014-10-17 00:00:00
- STATUS: ACTIVE
|
